Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) EBIT Margin: 2010-2024

Historic EBIT Margin for Cryo Cell International (CCEL) over the last 15 years, with FY2024 value amounting to 10.88%.

  • Cryo Cell International's EBIT Margin rose 70600.0% to 24.29% in Q3 2025 from the same period last year, while for Aug 2025 it was 13.63%, marking a year-over-year increase of 531200.0%. This contributed to the annual value of 10.88% for FY2024, which is 501400.0% up from last year.
  • As of FY2024, Cryo Cell International's EBIT Margin stood at 10.88%, which was up 501400.0% from 39.26% recorded in FY2023.
  • Cryo Cell International's 5-year EBIT Margin high stood at 24.6% for FY2020, and its period low was 39.26% during FY2023.
  • For the 5-year period, Cryo Cell International's EBIT Margin averaged around 4.68%, with its median value being 13.27% (2022).
  • As far as peak fluctuations go, Cryo Cell International's EBIT Margin crashed by -525200bps in 2023, and later soared by 501400bps in 2024.
  • Over the past 5 years, Cryo Cell International's EBIT Margin (Annual) stood at 24.6% in 2020, then tumbled by -43bps to 13.91% in 2021, then dropped by -5bps to 13.27% in 2022, then tumbled by -396bps to 39.26% in 2023, then skyrocketed by 128bps to 10.88% in 2024.
  • Its EBIT Margin stands at 10.88% for FY2024, versus 39.26% for FY2023 and 13.27% for FY2022.